Patents by Inventor Sidharth Chopra

Sidharth Chopra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indole compounds, process for the preparation and use thereof
    Patent number: 11718633
    Abstract: The present invention relates to an indole compound of Formula (I) or pharmaceutically acceptable salt thereof, and process for the preparation thereof. The present invention also relates to a pharmaceutical composition of indole compound of Formula (I) or pharmaceutically acceptable salt thereof for treating mycobacterial infection or antimalarial infection or antifungal infection in a subject in need thereof.
    Type: Grant
    Filed: May 15, 2019
    Date of Patent: August 8, 2023
    Assignee: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
    Inventors: Dumbala Srinivasa Reddy, Sidharth Chopra, Rahul Dilip Shingare, Sreenivasa Rao Ramana, Arunava Dasgupta
  • INDOLE COMPOUNDS, PROCESS FOR THE PREPARATION AND USE THEREOF
    Publication number: 20210238204
    Abstract: The present invention relates to an indole compound of Formula (I) or pharmaceutically acceptable salt thereof, and process for the preparation thereof. The present invention also relates to a pharmaceutical composition of indole compound of Formula (I) or pharmaceutically acceptable salt thereof for treating mycobacterial infection or antimalarial infection or antifungal infection in a subject in need thereof.
    Type: Application
    Filed: May 15, 2019
    Publication date: August 5, 2021
    Inventors: Dumbala Srinivasa REDDY, Sidharth CHOPRA, Rahul Dilip SHINGARE, Sreenivasa Rao RAMANA, Arunava DASGUPTA
  • Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis
    Publication number: 20170217908
    Abstract: Benzotriazine doxides are disclosed as drugs targeting mycobacterium tuberculosis, including novel compounds of formula I:
    Type: Application
    Filed: April 11, 2017
    Publication date: August 3, 2017
    Applicant: SRI INTERNATIONAL
    Inventors: Peter Madrid, Sidharth Chopra, Kenneth Ryan, Gary Koolpe
  • Benzotriazine oxides as drugs targeting
    Patent number: 9663478
    Abstract: Benzotriazine doxides are disclosed as drugs targeting mycobacterium tuberculosis, including novel compounds of formula I:
    Type: Grant
    Filed: December 23, 2012
    Date of Patent: May 30, 2017
    Assignee: SRI INTERNATIONAL
    Inventors: Peter Madrid, Sidharth Chopra, Kenneth Ryan, Gary Koolpe
  • Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis
    Publication number: 20130150369
    Abstract: Benzotriazine doxides are disclosed as drugs targeting mycobacterium tuberculosis, including novel compounds of formula I:
    Type: Application
    Filed: December 23, 2012
    Publication date: June 13, 2013
    Applicant: SRI INTERNATIONAL
    Inventors: Peter Madrid, Sidharth Chopra, Kenneth Ryan, Gary Koolpe
  • USE OF DEFENSINS AGAINST TUBERCULOSIS
    Publication number: 20110053836
    Abstract: The present invention relates to a method for killing or inhibiting cells of Mycobacterium, in particular M. tuberculosis, with certain defensins.
    Type: Application
    Filed: November 2, 2010
    Publication date: March 3, 2011
    Applicant: NOVOZYMES ADENIUM BIOTECH A/S
    Inventors: HANS-HENRIK KRISTENSEN HOGENHAUG, GARY K. SCHOOLNIK, SIDHARTH CHOPRA, DOROTEA RAVENTOS SEGURA
  • USE OF DEFENSINS AGAINST TUBERCULOSIS
    Publication number: 20090227506
    Abstract: The present invention relates to a method for killing or inhibiting cells of the genus Mycobacterium, in particular M. tuberculosis, with certain defensins.
    Type: Application
    Filed: March 4, 2009
    Publication date: September 10, 2009
    Applicant: Novozymes A/S
    Inventors: Hans-Henrik Kristensen Hogenhaug, Gary K. Schoolnik, Sidharth Chopra, Dorotea Raventos Segura